Finance
Banking, Economy & Business
Latest Articles (10000)
S&P 500 wavers after best one-day rally in six weeks: AlphaCheck
Former Wells Fargo asset manager Allspring explores $4bn sale
Deal by private equity owners would follow a string of transactions that have reshaped the industry
Travis Kelce and others lost millions in a Ponzi scheme. Here’s what a basic index fund would have earned them instead.
Investment scams cost Americans billions of dollars every year — how to protect yourself.
Under Armour: It May Become A Turnaround Play - But It Is Not Yet One
What Makes Ryan Specialty Holdings (RYAN) an Attractive Opportunity?
Is Dividend Investing Dead? What Died And What Didn't
Accenture (ACN) Positioned to Sustain Its Long-Term Competitive Position
Contemporary Amperex Technology: Addressing The Bear Case
Zoetis: The Worst May Be Priced In
Accenture: The Rebound Is Not Over
Mitsubishi Electric: Recent Developments Support Long-Term Targets
StealthGas: Cheap For A Reason, But The Setup May Be Changing
e.l.f. Beauty's Momentum Fatigue Triggers Attractive Dip Buying Opportunity
DHL AG (DHLGY) Deutsche Post AG - Analyst/Investor Day Transcript
Acorn Energy, Inc. (ACFN) Shareholder/Analyst Call Transcript
Microsoft: The Distribution Advantage Is Worth More Than Another Model Breakthrough
The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone.
Xenon Pharmaceuticals (XENE) voluntarily halted enrollment in a handful of studies Friday due to several unexpected side effects. The biotech stock crashed to a six-month low. The drug at the center o...